Page last updated: 2024-11-07

spironolactone and Premenstrual Tension

spironolactone has been researched along with Premenstrual Tension in 18 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Premenstrual Tension: A term used to describe the psychological aspects of PREMENSTRUAL SYNDROME, such as the indescribable tension, depression, hostility, and increased seizure activity in women with seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"To reevaluate whether spironolactone, a steroid receptor antagonist, is effective in improving premenstrual syndrome (PMS) in a double-blind, placebo-controlled cross over study."9.08Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. ( Bäckström, T; Hammarbäck, S; Lindhe, BA; Wang, M, 1995)
"A double blind placebo controlled randomized cross over study was conducted to assess the response to spironolactone by patients suffering from 'Premenstrual Syndrome'."9.07Premenstrual syndrome and spironolactone. ( Burnet, RB; Easterbrook, EG; McKinnon, RA; Radden, HS, 1991)
"The effect of spironolactone in the alleviation of the symptoms of the premenstrual syndrome was compared with placebo in a double-blind, parallel group controlled study."9.06A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. ( Akbar, FA; Pearce, MY; Shroff, NE; Stratford, ME; Vellacott, ID, 1987)
"To reevaluate whether spironolactone, a steroid receptor antagonist, is effective in improving premenstrual syndrome (PMS) in a double-blind, placebo-controlled cross over study."5.08Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study. ( Bäckström, T; Hammarbäck, S; Lindhe, BA; Wang, M, 1995)
"A double blind placebo controlled randomized cross over study was conducted to assess the response to spironolactone by patients suffering from 'Premenstrual Syndrome'."5.07Premenstrual syndrome and spironolactone. ( Burnet, RB; Easterbrook, EG; McKinnon, RA; Radden, HS, 1991)
"The effect of spironolactone in the alleviation of the symptoms of the premenstrual syndrome was compared with placebo in a double-blind, parallel group controlled study."5.06A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome. ( Akbar, FA; Pearce, MY; Shroff, NE; Stratford, ME; Vellacott, ID, 1987)
"The premenstrual syndrome is diagnosed historically, with symptoms recorded meticulously on a menstrual calendar."2.36Drug therapy for the premenstrual syndrome. ( Shangold, MM, 1983)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19909 (50.00)18.7374
1990's5 (27.78)18.2507
2000's4 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wyatt, K1
DEMARTINIS, C1
FONZO, D1
DELVAGLIO, B1
Rapkin, AJ2
Mikacich, JA1
Kroll, R1
Shangold, MM1
Simmons, MK1
Wang, M1
Hammarbäck, S1
Lindhe, BA1
Bäckström, T1
Johnson, SR1
Gianetto-Berruti, A1
Feyles, V1
O'Brien, PM2
Craven, D1
Selby, C1
Symonds, EM1
Hendler, N1
Hellberg, D1
Claesson, B1
Nilsson, S1
Burnet, RB1
Radden, HS1
Easterbrook, EG1
McKinnon, RA1
McMurchie, M1
Hindmarsh, E1
Vellacott, ID2
Shroff, NE1
Pearce, MY1
Stratford, ME1
Akbar, FA1

Reviews

8 reviews available for spironolactone and Premenstrual Tension

ArticleYear
Premenstrual syndrome.
    Clinical evidence, 2002, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cognitive Behavioral Therapy; Estrogen Replacement Therapy;

2002
[SECONDARY HYPERALDOSTERONISM. PHYSIOPATHOLOGIC, CLINICAL AND THERAPEUTIC CONSIDERATIONS].
    La Clinica terapeutica, 1963, Oct-15, Volume: 27

    Topics: Adrenal Cortex Hormones; Angiotensins; Blood Transfusion; Capillary Permeability; Diet; Diet Therapy

1963
Premenstrual syndrome in adolescents: diagnosis and treatment.
    Pediatric endocrinology reviews : PER, 2006, Volume: 3 Suppl 1

    Topics: Adolescent; Androstenes; Calcium; Female; Humans; Mood Disorders; Patient Education as Topic; Premen

2006
Treatment of premenstrual disorders.
    The Journal of reproductive medicine, 2006, Volume: 51, Issue:4 Suppl

    Topics: Alprazolam; Androstenes; Cognitive Behavioral Therapy; Contraceptives, Oral; Exercise; Female; Gonad

2006
Drug therapy for the premenstrual syndrome.
    The Journal of reproductive medicine, 1983, Volume: 28, Issue:8

    Topics: Bromocriptine; Female; Humans; Premenstrual Syndrome; Progesterone; Pyridoxine; Spironolactone; Synd

1983
Premenstrual syndrome therapy.
    Clinical obstetrics and gynecology, 1998, Volume: 41, Issue:2

    Topics: Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Contraceptives, Oral, C

1998
Premenstrual syndrome.
    Minerva ginecologica, 2002, Volume: 54, Issue:2

    Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Contraceptives, Oral; Danazol; Diagnosis, Differentia

2002
Effect of spironolactone on premenstrual syndrome symptoms.
    The Journal of reproductive medicine, 1987, Volume: 32, Issue:6

    Topics: Adult; Aldosterone; Body Water; Body Weight; Diuretics; Female; Humans; Premenstrual Syndrome; Renin

1987

Trials

5 trials available for spironolactone and Premenstrual Tension

ArticleYear
Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Acta obstetricia et gynecologica Scandinavica, 1995, Volume: 74, Issue:10

    Topics: Adult; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Humans; Menstrual Cycle

1995
Treatment of premenstrual syndrome by spironolactone.
    British journal of obstetrics and gynaecology, 1979, Volume: 86, Issue:2

    Topics: Aldosterone; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Menstruatio

1979
Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1991, Volume: 34, Issue:3

    Topics: Adult; Drug Evaluation; Female; Humans; Medroxyprogesterone; Middle Aged; Placebos; Premenstrual Syn

1991
Premenstrual syndrome and spironolactone.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1991, Volume: 31, Issue:4

    Topics: Androgens; Depression; Double-Blind Method; Female; Humans; Premenstrual Syndrome; Spironolactone

1991
A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.
    Current medical research and opinion, 1987, Volume: 10, Issue:7

    Topics: Adult; Aldosterone; Double-Blind Method; Drug Evaluation; Female; Humans; Middle Aged; Patient Dropo

1987

Other Studies

5 other studies available for spironolactone and Premenstrual Tension

ArticleYear
[Studies on the actions of 17-spirolactones. I. Action on the premenstrual syndrome].
    Acta gynaecologica et obstetrica Hispano-Lusitana, 1960, Volume: 9

    Topics: Female; Humans; Lactones; Premenstrual Syndrome; Spironolactone

1960
[EDEMAS AND SPIRONOLACTONES].
    La Riforma medica, 1964, Aug-01, Volume: 78

    Topics: Edema; Female; Glomerulonephritis; Humans; Nephritis; Pregnancy; Pregnancy Complications; Premenstru

1964
Possible new relief for premenstrual syndrome.
    JAMA, 1983, Sep-16, Volume: 250, Issue:11

    Topics: Female; Humans; Premenstrual Syndrome; Spironolactone; Syndrome

1983
Spironolactone for the treatment of PMS.
    Maryland medical journal (Baltimore, Md. : 1985), 1992, Volume: 41, Issue:4

    Topics: Buspirone; Female; Humans; Premenstrual Syndrome; Spironolactone

1992
Premenstrual syndrome. A general practice view.
    Australian family physician, 1989, Volume: 18, Issue:2

    Topics: Contraceptives, Oral; Female; Humans; Life Style; Mefenamic Acid; Premenstrual Syndrome; Pyridoxine;

1989